Page 13 - Aesthetics&Dermatology_11_2018
P. 13
PRESS RELEASE
Reference:
12 [ii] See more about chronic rhinitis
here: http://www.worldallergy.org/
corticosteroid, mometasone[iv], education-and-programs/education/
with Nexa AllerShield™. The All four Nexa allergic-disease-resource-center/
treatments were found to be professionals/in-depth-review-of-
comparable in controlling symptoms products will allergic-rhinitis
of allergic rhinitis. The severity be available
of sneezing, runny nose, tearing, at all leading [iii] Allergy Foundation of South
nasal congestion, itchy eyes and pharmacies Africa: http://www.allergyfoundation.
scratchy throat were evaluated at from November co.za/allergy-and-immunology/
the onset, 14 days and 28 days allergy/
after treatment. onwards and
retails for R [iv] Mahmoodi NS et al. The
Nexa AllerShield™ substantially 134.40 (incl. comparison of Nasaleze and
improves the rate of Nasal Mucus VAT). Mometasone nasal spray to control
Clearance and PNIFR (Peak the symptoms of allergic rhinitis.
Nasal Inspiratory Flow Rate)[v] Advanced Biomedical Research
and reduces the need for rescue 2018; 7:27-31 (Nexa is marketed as
medication[vi]. The efficacy of Nexa Nasaleze in Europe.)
AllerShield™ is similar to that of
steroidal nasal sprays in controlling [v] Aivazis, Bourli, Maratou et al.
symptoms of allergic rhinitis. It can normally, while trapping allergens Measure of improvement in nasal
therefore be used as an alternative and viruses from contact with the mucociliary clearance and PNIFR
for corticosteroids, particularly in nasal membrane.” (peak nasal inspiratory flow rate)
children older than 18 months, as in children with allergic rhinitis.
well as pregnant and breast-feeding In one of the trials using Nexa Chronica, June 2005, Vol 5 no 2.
women. It is also recommended as FluShield™, researchers noted Open Clinical Trial
add-on treatment to antihistamine an illness incidence decrease in
use.[vii] 90 % of patients, and the duration [vi] Emberlain JC and Lewis RA, A
(in days) of upper respiratory tract double blind, placebo-controlled trial
During clinical trials, 85 % of infections (URTI) also decreased of inert cellulose powder for the relief
chronic hay fever sufferers reported by 2,5 times compared to the same of symptoms of hay fever in adults.
a significant improvement in allergy period in the previous year[ix]. Current Medical Research and
symptoms after only three weeks of Local experts have described Nexa Opinion 2006;22(2):275-285
use[viii]. After a further three weeks, as a game-changer in the way
90 % of participants said their nasal allergies and congestion will [vii] Todor A. Popov, Nils Åberg
symptoms had vastly improved. be treated in South Africa going et al. Methyl-cellulose powder for
forward. prevention and management of nasal
Nexa AllerShield™ is also non- symptoms. 2017. Expert review of
drowsy and medicine-free, which All four Nexa products will be respiratory medicine. https://doi.org/1
means it can be used by children available at all leading pharmacies 0.1080/17476348.2017.1375408.
(older than 18 months) and from November onwards and retails
pregnant or breast-feeding women. for R 134.40 (incl. VAT). [viii] Josling P and Steadman S,
Use of Cellulose Powder for the
Nexa is available in four variations, Note that Nexa AllerShield™ is Treatment of Seasonal Allergic
namely Nexa AllerShield™, not suitable for use in children Rhinitis Adv Ther. 2003 Jul-
Nexa Allershield Junior™, under 18 months or individuals Aug;20(4):210-9. Open Clinical Trial
Nexa TravelShield™ and Nexa who are sensitive to cellulose and/
FluShield™ and are all underpinned or mint. Nexa Allershield Junior™ [ix] Nasaleze clinical trials: Use
by clinical studies. is not suitable for use in children of Nasaleze Cold as a prevention
under 18 months or individuals method for acute respiratory
Jennings highlights that the who are sensitive to cellulose and/ illnesses in paediatric practice. (Nexa
device has also been proven to be or strawberry. Nexa TravelShield™ FluShield is marketed as Nasaleze
effective in combating viruses due and Nexa FluShield™ is not Cold in Europe.)
to it creating a protective ‘shield’ suitable for children under 3 years
in the nose. “It acts as a fine filter, or individuals who are sensitive to
which allows the patient to breathe cellulose, mint or garlic.
13
